Low-Dose Intravenous Paracetamol for Patent Ductus Arteriosus in Indomethacin-Resistant or Contraindicated Preterm Infants: Three Cases Reports

• Main Authors: Shun Matsumura (Author), Ayumi Oshima (Author), Sumie Fujinuma (Author), Kosuke Tanaka (Author), Nobuhiko Nagano (Author), Fuyu Miyake (Author), Satoshi Masutani (Author), Masanori Tamura (Author), Keiko Ueda (Author), Fumihiko Namba (Author)
• Format: Book
• Published: Thieme Medical Publishers, Inc., 2017-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Although indomethacin (IND) is the standard treatment for hemodynamically significant patent ductus arteriosus (hsPDA) in Japan, it may be associated with renal impairment and gastrointestinal complications. The use of paracetamol for hsPDA closure has recently increased. Unlike...